Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231.
Chemoimmunotherapy with adjuvant CL/MAb 231 offers an alternative treatment approach for canine lymphoma. Results of treatment and prognostic factors are discussed and compared with previously published chemotherapy results.
Jeglum
K A
KA
Veterinary Oncology Services and Research Center, West Chester, Pennsylvania, USA.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004283:Dog Diseases / Q000628:therapy*; D004285:Dogs; D004358:Drug Therapy / Q000592:standards / Q000662:veterinary; D007167:Immunotherapy / Q000592:standards / Q000662:veterinary*; D008223:Lymphoma / Q000628:therapy / Q000662:veterinary*
D000911:Antibodies, Monoclonal